TIAA CREF Investment Management’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
Sell
-650,350
Closed -$228 3162
2016
Q3
$228 Hold
650,350
﹤0.01% 3036
2016
Q2
$303K Buy
650,350
+111,742
+21% +$52.1K ﹤0.01% 3030
2016
Q1
$733K Hold
538,608
﹤0.01% 2631
2015
Q4
$792K Hold
538,608
﹤0.01% 2715
2015
Q3
$851K Buy
538,608
+13,334
+3% +$21.1K ﹤0.01% 2663
2015
Q2
$893K Buy
525,274
+83,972
+19% +$143K ﹤0.01% 2746
2015
Q1
$613K Buy
441,302
+21,473
+5% +$29.8K ﹤0.01% 2857
2014
Q4
$634K Sell
419,829
-27,303
-6% -$41.2K ﹤0.01% 2883
2014
Q3
$921K Sell
447,132
-21,451
-5% -$44.2K ﹤0.01% 2676
2014
Q2
$1.43M Sell
468,583
-376,221
-45% -$1.15M ﹤0.01% 2499
2014
Q1
$2.11M Buy
844,804
+231,456
+38% +$579K ﹤0.01% 2207
2013
Q4
$3.04M Buy
613,348
+312,335
+104% +$1.55M ﹤0.01% 1983
2013
Q3
$683K Sell
301,013
-22,191
-7% -$50.4K ﹤0.01% 2840
2013
Q2
$718K Buy
+323,204
New +$718K ﹤0.01% 2788